Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia.
about
Malignant vasovagal syncope: a randomised trial of metoprolol and clonidineRecurrent asystoles associated with vasovagal reaction during venipunctureFludrocortisone in the treatment of hypotensive disorders in the elderlyEfficacy and safety of clonazepam in refractory neurally mediated syncope.Management of vasovagal syncope.Driving safety among patients with neurocardiogenic (vasovagal) syncope.A review of pathophysiology and therapy of patients with vasovagal syncope.Role of carotid sinus syndrome and neurocardiogenic syncope in recurrent syncope and falls in patients referred to an outpatient clinic in a district general hospital.The use of head-upright tilt table testing in the evaluation and management of syncope in children and adolescents.Recurrent unexplained syncope in the elderly: the use of head-upright tilt table testing in evaluation and management.Head-upright tilt-table testing: a useful tool in the evaluation and management of recurrent vertigo of unknown origin associated with near-syncope or syncope.Hemodynamic significance of heart rate in neurally mediated syncope.Neurocardiogenic syncope: latest pharmacological therapies.Can we treat carotid sinus syndrome?Tilt table testing for evaluation of neurally-mediated (cardioneurogenic) syncope: rationale and proposed protocols.Preliminary observations on the effect of amitriptyline treatment in preventing syncope recurrence in patients with vasovagel syncope.Diagnosing syncope. With an emphasis on cardiac causes.Exercise-induced vasovagal syncope: limiting the risks.Vasovagal syncope: an update on the latest pharmacological therapies.Low dose disopyramide often fails to prevent neurogenic syncope during head-up tilt testing.Short AV interval VDD pacing does not prevent tilt induced vasovagal syncope in patients with cardioinhibitory vasovagal syndrome.Efficacy of different treatment strategies for neurocardiogenic syncope.Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope.Beneficial effects of dextro-amphetamine in the treatment of vasodepressor syncope.Head-up tilt testing. The balance of evidence.Exercise induced vasodepressor syncope.Permanent pacing for cardioinhibitory malignant vasovagal syndrome.Syncope in older persons.Cardiac pacing during neurocardiogenic (vasovagal) syncope.Syncope: pathophysiology, diagnosis, and pharmacotherapy.Response to beta blockers in patients with neurocardiogenic syncope: how to predict beneficial effects.Neurally mediated syncopal syndromes: pathophysiological concepts and clinical evaluation.Clinical experience with Thera DR rate-drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope. The International Rate-Drop Investigators Group.Efficacy of midodrine hydrochloride in neurocardiogenic syncope refractory to standard therapy.Midodrine: a role in the management of neurocardiogenic syncope.Drug therapy considerations in arrhythmias in childrenHead-up tilt testing: the balance of evidence.
P2860
Q24563053-CAD56644-2928-4F73-A660-937454D92BDBQ28359890-77F15435-AE0F-415E-BB12-683BCD1829A2Q28379442-C72384D7-64A4-400E-B8F0-F90B8EA6B830Q33144565-1F484072-A2D5-40A9-991C-AF2DD04271ADQ33144810-B139BC85-D578-4CC7-985A-476F633BF434Q33145173-E6FE2212-C2C6-469D-BF84-D973181BC9C0Q33145280-069B1CC2-D154-4F1F-8FB2-BA58010A78E5Q33145578-E1418630-475E-43EC-89EC-B4B0415C67F3Q33149893-7377AD25-09DE-4B13-9DF3-E14EDFF0F793Q33150041-9D88D3FB-26EA-4FE6-9E4A-60238D89466AQ33150464-1F3B7596-3F54-4453-94B2-E85210ECF4BDQ33152094-51FE2ED8-15A5-4DD9-AA9F-3519D82F730BQ33153898-D6B4E9EF-DC7C-4A4F-8C84-B56F23569D85Q33154618-AFB7AFA8-EEBE-4C63-BAFD-4DF4CC2CDE02Q33154635-F4315A25-7B15-4DA9-95FD-EDF41EE32020Q33155276-9752B79E-4F3C-4582-8EB3-E47F8177C052Q33157138-220A1213-23D3-43B6-A198-BFB396D2D85DQ33158261-62A91F7A-9E80-42C5-98EB-EBC580E37CCBQ33165101-F05DB27C-AA77-4F50-AD05-98B7E07F4A65Q33173549-8131A5B5-B51C-41EE-8800-23B27B37635DQ33173553-A41A1289-D5A0-4C27-B9E3-EFC1448B294DQ33173624-C831DF37-B5E9-4D75-93F3-6AB7A535C74EQ33173716-9FF976A0-A068-4160-A8E9-63698FD8A1B4Q33173728-4AA7943F-1560-45D9-898D-7A2A045810E3Q33173964-3AF6AC78-03AD-467E-BE58-9A80E9769B2CQ33174060-7E649759-2F25-4BB4-A8DA-46A51E5D4E9EQ33174143-04D933D1-4DCA-4A89-943F-79C1CAA60A0AQ33174145-F980A4B7-15D4-415A-BC55-30D2D76DA26AQ33174586-D80F9FED-88E5-4720-816D-32574500C7C5Q33174903-D65EAFC3-CCAA-4EFA-8057-4E99C8AEF5F7Q33174985-D7F50515-8262-46EF-B0DB-37ACC33033D5Q33175048-C71E2FED-7E22-43C9-9B8B-22EC100288F0Q33175094-15BCE976-0AF2-4569-8764-116754EF2440Q33175138-64FF60D0-A1C4-46AD-9E87-B08F313B4FE0Q33175537-1CA9C3C0-608E-43D1-B664-9821FECDA521Q37235054-E6D248AE-E80B-400F-9FA3-10AF64909932Q42393575-A1E16584-B9F7-4A5B-B71B-8F17881303AA
P2860
Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia.
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Usefulness of disopyramide for ...... duced hypotension-bradycardia.
@ast
Usefulness of disopyramide for ...... duced hypotension-bradycardia.
@en
type
label
Usefulness of disopyramide for ...... duced hypotension-bradycardia.
@ast
Usefulness of disopyramide for ...... duced hypotension-bradycardia.
@en
prefLabel
Usefulness of disopyramide for ...... duced hypotension-bradycardia.
@ast
Usefulness of disopyramide for ...... duced hypotension-bradycardia.
@en
P2093
P1476
Usefulness of disopyramide for ...... duced hypotension-bradycardia.
@en
P2093
Benditt DG
Buetikofer J
Dunnigan A
Milstein S
P304
P356
10.1016/0002-9149(90)91324-Y
P407
P577
1990-06-01T00:00:00Z